Miracor's cardiac perfusion technology enters first human trial
This article was originally published in Clinica
Executive Summary
Miracor Medical Systems has begun the first human trial of the PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) system. The system is designed to improve blood flow to the heart muscle following percutaneous coronary intervention (PCI) to help repair cardiac tissue in patients with acute coronary syndrome (ACS).